A detailed history of Frg Family Wealth Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Frg Family Wealth Advisors LLC holds 3,205 shares of VRTX stock, worth $1.5 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
3,205
Previous 3,217 0.37%
Holding current value
$1.5 Million
Previous $1.51 Million 1.13%
% of portfolio
0.27%
Previous 0.22%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$460.0 - $505.78 $5,520 - $6,069
-12 Reduced 0.37%
3,205 $1.49 Million
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $30,576 - $33,456
-75 Reduced 2.28%
3,217 $1.34 Million
Q3 2023

Oct 11, 2023

BUY
$338.18 - $362.46 $10,145 - $10,873
30 Added 0.92%
3,292 $1.14 Million
Q2 2023

Jul 13, 2023

BUY
$314.42 - $351.91 $3,144 - $3,519
10 Added 0.31%
3,262 $1.15 Million
Q1 2023

Apr 18, 2023

SELL
$283.23 - $323.1 $69,391 - $79,159
-245 Reduced 7.01%
3,252 $1.02 Million
Q3 2022

Oct 12, 2022

SELL
$273.83 - $305.53 $11,774 - $13,137
-43 Reduced 1.21%
3,497 $1.01 Million
Q2 2022

Jul 11, 2022

BUY
$234.96 - $292.55 $23,496 - $29,255
100 Added 2.91%
3,540 $998,000
Q1 2022

May 06, 2022

BUY
$221.42 - $260.97 $4,428 - $5,219
20 Added 0.58%
3,440 $898,000
Q4 2021

Feb 09, 2022

BUY
$177.01 - $223.45 $38,057 - $48,041
215 Added 6.71%
3,420 $751,000
Q3 2021

Mar 02, 2022

BUY
$181.39 - $202.99 $26,301 - $29,433
145 Added 4.74%
3,205 $581,000
Q2 2021

Mar 02, 2022

BUY
$187.49 - $221.1 $573,719 - $676,566
3,060 New
3,060 $617,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Frg Family Wealth Advisors LLC Portfolio

Follow Frg Family Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frg Family Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frg Family Wealth Advisors LLC with notifications on news.